Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
26.80
-2.42 (-8.28%)
At close: Nov 16, 2026, 4:00 PM EST
26.90
+0.10 (0.37%)
After-hours: Nov 16, 2026, 4:06 PM EST

Viking Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-627.2-359.64-109.96-85.9-68.87-54.99
Depreciation & Amortization
0.490.430.350.290.290.3
Other Amortization
-0.060.090.090.060.02
Loss (Gain) From Sale of Investments
-4.78-9.34-17.38-8.21.223.91
Stock-Based Compensation
47.9540.8229.7116.758.676.1
Other Operating Activities
0.190.010.040.040.040.01
Change in Accounts Payable
77.7243.442.3-1.027.09-2.54
Change in Other Net Operating Assets
42.995.547.064.573.1-0.38
Operating Cash Flow
-462.63-278.69-87.79-73.38-48.4-47.59
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Investment in Securities
331.75341.39-553.37-179.0954.7537.96
Investing Cash Flow
331.75341.39-553.37-179.0954.7537.96

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt Issued (Repaid)
251-----
Issuance of Common Stock
457.3276.44654.57278.512.517.63
Repurchase of Common Stock
---42.1-7.12-8.33-0.71
Other Financing Activities
-----0.02-0.05
Financing Cash Flow
708.3276.44612.46271.384.166.88

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0-0.01-0.15-0.03-0.26-
Net Cash Flow
577.44139.13-28.8418.8810.26-2.75

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-237.78-160.22-55.58-42.36-25.22-32.16
Unlevered Free Cash Flow
-237.72-160.24-55.61-42.4-25.24-32.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
120.7148.989.363.5510.19-2.93
SEC Filings: 10-K · 10-Q